Abstract
The traditional healthcare model is focused on diseases (medicine and natural science) and does not acknowledge patients’ resources and abilities to be experts in their own lives based on their lived experiences. Improving healthcare safety, quality, and coordination, as well as quality of life, is an important aim in the care of patients with chronic conditions. Person-centered care needs to ensure that people's values and preferences guide clinical decisions. This paper reviews current knowledge to develop (1) digital care pathways for rhinitis and asthma multimorbidity and (2) digitally enabled, person-centered care.1 It combines all relevant research evidence, including the so-called real-world evidence, with the ultimate goal to develop digitally enabled, patient-centered care. The paper includes (1) Allergic Rhinitis and its Impact on Asthma (ARIA), a 2-decade journey, (2) Grading of Recommendations, Assessment, Development and Evaluation (GRADE), the evidence-based model of guidelines in airway diseases, (3) mHealth impact on airway diseases, (4) From guidelines to digital care pathways, (5) Embedding Planetary Health, (6) Novel classification of rhinitis and asthma, (7) Embedding real-life data with population-based studies, (8) The ARIA-EAACI (European Academy of Allergy and Clinical Immunology) strategy for the management of airway diseases using digital biomarkers, (9) Artificial intelligence, (10) The development of digitally enabled, ARIA person-centered care, and (11) The political agenda. The ultimate goal is to propose ARIA 2024 guidelines centered around the patient to make them more applicable and sustainable.
Original language | English |
---|---|
Journal | Journal of Allergy and Clinical Immunology: In Practice |
DOIs | |
Publication status | Accepted/In press - Jul 2024 |
Keywords
- ARIA
- Artificial intelligence
- Asthma
- Evidence-based medicine
- mHealth
- Person-centered care
- Rhinitis
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Journal of Allergy and Clinical Immunology: In Practice, 07.2024.
Research output: Contribution to journal › Review article › peer-review
TY - JOUR
T1 - Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
AU - Bousquet, Jean
AU - Schünemann, Holger J.
AU - Sousa-Pinto, Bernardo
AU - Zuberbier, Torsten
AU - Togias, Alkis
AU - Samolinski, Boleslaw
AU - Bedbrook, Anna
AU - Czarlewski, Wienczyslawa
AU - Hofmann-Apitius, Martin
AU - Litynska, Justyna
AU - Vieira, Rafael José
AU - Anto, Josep M.
AU - Fonseca, Joao A.
AU - Brozek, Jan
AU - Bognanni, Antonio
AU - Brussino, Luisa
AU - Canonica, G. Walter
AU - Cherrez-Ojeda, Ivan
AU - Cruz, Alvaro A.
AU - Vecillas, Leticia de las
AU - Dykewicz, Mark
AU - Gemicioglu, Bilun
AU - Giovannini, Mattia
AU - Haahtela, Tari
AU - Jacobs, Marc
AU - Jacomelli, Cristina
AU - Klimek, Ludger
AU - Kvedariene, Violeta
AU - Larenas-Linnemann, Desiree E.
AU - Louis, Gilles
AU - Lourenço, Olga
AU - Leemann, Lucas
AU - Morais-Almeida, Mario
AU - Neves, Ana Luisa
AU - Nadeau, Kari C.
AU - Nowak, Artur
AU - Palamarchuk, Yuliia
AU - Palkonen, Susanna
AU - Papadopoulos, Nikolaos G.
AU - Parmelli, Elena
AU - Pereira, Ana Margarida
AU - Pfaar, Oliver
AU - Regateiro, Frederico S.
AU - Savouré, Marine
AU - Taborda-Barata, Luis
AU - Toppila-Salmi, Sanna K.
AU - Torres, Maria J.
AU - Valiulis, Arunas
AU - Ventura, Maria Teresa
AU - Williams, Sian
AU - Yepes-Nuñez, Juan J.
AU - Yorgancioglu, Arzu
AU - Zhang, Luo
AU - Zuberbier, Jaron
AU - Abdul Latiff, Amir Hamzah
AU - Abdullah, Baharudin
AU - Agache, Ioana
AU - Al-Ahmad, Mona
AU - Al-Nesf, Maryam Ali
AU - Al Shaikh, Nada A.
AU - Amaral, Rita
AU - Ansotegui, Ignacio J.
AU - Asllani, Julijana
AU - Balotro-Torres, Maria Cristina
AU - Bergmann, Karl Christian
AU - Bernstein, Jonathan A.
AU - Bindslev-Jensen, Carsten
AU - Blaiss, Michael S.
AU - Bonaglia, Cristina
AU - Bonini, Matteo
AU - Bossé, Isabelle
AU - Braido, Fulvio
AU - Caballero-Fonseca, Fernan
AU - Camargos, Paulo
AU - Carreiro-Martins, Pedro
AU - Casale, Thomas
AU - Castillo-Vizuete, José Antonio
AU - Cecchi, Lorenzo
AU - Teixeira, Maria do Ceu
AU - Chang, Yoon Seok
AU - Loureiro, Claudia Chaves
AU - Christoff, George
AU - Ciprandi, Giorgio
AU - Cirule, Ieva
AU - Correia-de-Sousa, Jaime
AU - Costa, Elisio M.
AU - Cvetkovski, Biljana
AU - de Vries, Govert
AU - Del Giacco, Stefano
AU - Devillier, Philippe
AU - Dokic, Dejan
AU - Douagui, Habib
AU - Durham, Stephen R.
AU - Enecilla, Maria Lourdes
AU - Fiocchi, Alessandro
AU - Fokkens, Wytske J.
AU - Fontaine, Jean François
AU - Gawlik, Radoslaw
AU - Gereda, Jose E.
AU - Gil-Mata, Sara
AU - Giuliano, Antonio F.M.
AU - Gotua, Maia
AU - Gradauskiene, Brigita
AU - Guzman, Maria Antonieta
AU - Hossny, Elham
AU - Hrubiško, Martin
AU - Iinuma, Tomohisa
AU - Irani, Carla
AU - Ispayeva, Zhanat
AU - Ivancevich, Juan Carlos
AU - Jartti, Tuomas
AU - Jeseňák, Miloš
AU - Julge, Kaja
AU - Jutel, Marek
AU - Kaidashev, Igor
AU - Bennoor, Kazi S.
AU - Khaltaev, Nicolai
AU - Kirenga, Bruce
AU - Kraxner, Helga
AU - Kull, Inger
AU - Kulus, Marek
AU - Kuna, Piotr
AU - Kupczyk, Maciej
AU - Kurchenko, Andriy
AU - La Grutta, Stefania
AU - Lane, Stephen
AU - Miculinic, Neven
AU - Lee, Sang Min
AU - Le Thi Tuyet, Lan
AU - Lkhagvaa, Battur
AU - Louis, Renaud
AU - Mahboub, Bassam
AU - Makela, Mika
AU - Makris, Michael
AU - Maurer, Marcus
AU - Melén, Eric
AU - Milenkovic, Branislava
AU - Mohammad, Yousser
AU - Moniuszko, Marcin
AU - Montefort, Stephen
AU - Moreira, Andre
AU - Moreno, Pablo
AU - Mullol, Joaquim
AU - Nadif, Rachel
AU - Nakonechna, Alla
AU - Navarro-Locsin, Cecilia Gretchen
AU - Neffen, Hugo E.
AU - Nekam, Kristof
AU - Niedoszytko, Marek
AU - Nunes, Elizabete
AU - Nyembue, Dieudonné
AU - O'Hehir, Robyn
AU - Ollert, Markus
AU - Ohta, Ken
AU - Okamoto, Yoshitaka
AU - Okubo, Kimihiro
AU - Olze, Heidi
AU - Padukudru, Mahesh Anand
AU - Palomares, Oscar
AU - Pali-Schöll, Isabella
AU - Panzner, Petr
AU - Palosuo, Kati
AU - Park, Hae S.
AU - Passalacqua, Giovanni
AU - Patella, Vincenzo
AU - Pawankar, Ruby
AU - Pétré, Benoît
AU - Pitsios, Constantinos
AU - Plavec, Davor
AU - Popov, Todor A.
AU - Puggioni, Francesca
AU - Quirce, Santiago
AU - Raciborski, Filip
AU - Ramonaité, Agné
AU - Recto, Marysia
AU - Repka-Ramirez, Susana
AU - Roberts, Graham
AU - Robles-Velasco, Karla
AU - Roche, Nicolas
AU - Rodriguez-Gonzalez, Monica
AU - Romualdez, Joel A.
AU - Rottem, Menachem
AU - Rouadi, Philip W.
AU - Salapatas, Marianella
AU - Sastre, Joaquin
AU - Serpa, Faradiba S.
AU - Sayah, Zineb
AU - Scichilone, Nicola
AU - Senna, Gianenrico
AU - Sisul, Juan Carlos
AU - Solé, Dirceu
AU - Soto-Martinez, Manuel E.
AU - Sova, Milan
AU - Sozinova, Olga
AU - Stevanovic, Katarina
AU - Ulrik, Charlotte Suppli
AU - Szylling, Anna
AU - Tan, Frances M.
AU - Tantilipikorn, Pongsakorn
AU - Todo-Bom, Ana
AU - Tomic-Spiric, Vesna
AU - Tsaryk, Vladyslav
AU - Tsiligianni, Ioanna
AU - Urrutia-Pereira, Marilyn
AU - Rostan, Marylin Valentin
AU - Sofiev, Mikhail
AU - Valovirta, Erkka
AU - Van Eerd, Michiel
AU - Van Ganse, Eric
AU - Vasankari, Tuula
AU - Vichyanond, Pakit
AU - Viegi, Giovanni
AU - Wallace, Dana
AU - Wang, De Yun
AU - Waserman, Susan
AU - Wong, Gary
AU - Worm, Margitta
AU - Yusuf, Osman M.
AU - Zaitoun, Fares
AU - Zidarn, Mihaela
N1 - Funding Information: This work has received funding from ARIA (Allergic Rhinitis and its Impact of Asthma); CATALYSE (Climate Action To Advance HeaLthY Societies in Europe), the European Union\u2019s Horizon Europe research and innovation program under grant agreement no. 101057131; FRAUNHOFER Institute for Translational Medicine and Pharmacology (ITMP), Immunology and Allergology, Berlin, Germany; University of Porto, Portugal; and MASK-air, which has been supported by EU grants (Impact of air Pollution on Asthma and Rhinitis [POLLAR] project of the European Institute of Innovation and Technology Health; Structural and Development Funds, R\u00E9gion Languedoc Roussillon and Provence-Alpes-C\u00F4te d\u2019Azur; Twinning, European Innovation Partnership on Active and Healthy Ageing, DG Sant\u00E9 and DG Connect); educational grants from Mylan-Viatris, Allergologisk Laboratorium K\u00F8benhavn, GlaxoSmithKline, Novartis, Stallerg\u00E8nes-Greer, and Noucor; and funding from Breathing Together Onlus Association (Associazione Respiriamo Insieme Onlus), Italy; Esp\u00EDritu Santo University, Samborond\u00F3n, Ecuador; Finnish Anti-Tuberculosis Association Foundation and Tampere Tuberculosis Foundation; GA 2 LEN; German Allergy Society AeDA (\u00C4rzteverband Deutscher Allergologen); IPOKRaTES (International Postgraduate Organization for Knowledge transfer, Research and Teaching Excellent Students) Lithuania Fund; Polish Society of Allergology (POLSKIE TOWARZYSTWO ALLERGOLOGICZNE); and University of Li\u00E8ge, Belgium. Funding Information: Conflicts of interest: J. Bousquet reports personal fees from Cipla, Menarini, Mylan, Novartis, Purina, Sanofi-Aventis, Teva, Noucor, other from KYomed-Innov, and other from Mask-air-SAS, outside the submitted work. M. Blaiss reports personal fees from Sanofi, personal fees from Regeneron, personal fees from ALK, personal fees from Merck, personal fees from AstraZeneca, personal fees from GSK, personal fees from Prollergy, personal fees from Lanier Biotherapeutics, and nonfinancial support from Bryn Phama, outside the submitted work. J. Lity\u0144ska reports personal fees from Evidence Prime Sp. z o.o., outside the submitted work. T. Iinuma reports grants from Sanofi, outside the submitted work. P. Tantilipikorn reports grants from Abbott, other from GSK, and other from Sanofi Aventis, outside the submitted work. T. Haahtela reports personal fees from Orion Pharma, outside the submitted work. Publisher Copyright: © 2024 The Authors
PY - 2024/7
Y1 - 2024/7
N2 - The traditional healthcare model is focused on diseases (medicine and natural science) and does not acknowledge patients’ resources and abilities to be experts in their own lives based on their lived experiences. Improving healthcare safety, quality, and coordination, as well as quality of life, is an important aim in the care of patients with chronic conditions. Person-centered care needs to ensure that people's values and preferences guide clinical decisions. This paper reviews current knowledge to develop (1) digital care pathways for rhinitis and asthma multimorbidity and (2) digitally enabled, person-centered care.1 It combines all relevant research evidence, including the so-called real-world evidence, with the ultimate goal to develop digitally enabled, patient-centered care. The paper includes (1) Allergic Rhinitis and its Impact on Asthma (ARIA), a 2-decade journey, (2) Grading of Recommendations, Assessment, Development and Evaluation (GRADE), the evidence-based model of guidelines in airway diseases, (3) mHealth impact on airway diseases, (4) From guidelines to digital care pathways, (5) Embedding Planetary Health, (6) Novel classification of rhinitis and asthma, (7) Embedding real-life data with population-based studies, (8) The ARIA-EAACI (European Academy of Allergy and Clinical Immunology) strategy for the management of airway diseases using digital biomarkers, (9) Artificial intelligence, (10) The development of digitally enabled, ARIA person-centered care, and (11) The political agenda. The ultimate goal is to propose ARIA 2024 guidelines centered around the patient to make them more applicable and sustainable.
AB - The traditional healthcare model is focused on diseases (medicine and natural science) and does not acknowledge patients’ resources and abilities to be experts in their own lives based on their lived experiences. Improving healthcare safety, quality, and coordination, as well as quality of life, is an important aim in the care of patients with chronic conditions. Person-centered care needs to ensure that people's values and preferences guide clinical decisions. This paper reviews current knowledge to develop (1) digital care pathways for rhinitis and asthma multimorbidity and (2) digitally enabled, person-centered care.1 It combines all relevant research evidence, including the so-called real-world evidence, with the ultimate goal to develop digitally enabled, patient-centered care. The paper includes (1) Allergic Rhinitis and its Impact on Asthma (ARIA), a 2-decade journey, (2) Grading of Recommendations, Assessment, Development and Evaluation (GRADE), the evidence-based model of guidelines in airway diseases, (3) mHealth impact on airway diseases, (4) From guidelines to digital care pathways, (5) Embedding Planetary Health, (6) Novel classification of rhinitis and asthma, (7) Embedding real-life data with population-based studies, (8) The ARIA-EAACI (European Academy of Allergy and Clinical Immunology) strategy for the management of airway diseases using digital biomarkers, (9) Artificial intelligence, (10) The development of digitally enabled, ARIA person-centered care, and (11) The political agenda. The ultimate goal is to propose ARIA 2024 guidelines centered around the patient to make them more applicable and sustainable.
KW - ARIA
KW - Artificial intelligence
KW - Asthma
KW - Evidence-based medicine
KW - mHealth
KW - Person-centered care
KW - Rhinitis
UR - http://www.scopus.com/inward/record.url?scp=85203816908&partnerID=8YFLogxK
U2 - 10.1016/j.jaip.2024.06.040
DO - 10.1016/j.jaip.2024.06.040
M3 - Review article
C2 - 38971567
AN - SCOPUS:85203816908
SN - 2213-2198
JO - Journal of Allergy and Clinical Immunology: In Practice
JF - Journal of Allergy and Clinical Immunology: In Practice
ER -